TakeCare, Non-Invasive Diagnosis of Early Liver Damage from immunosorbent assay Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Description: Liver pathologies are extending along the population and present a global health problem. According to the World Health, 1.7 billion people suffer from NAFLD and about 2 million patients die annually from cirrhosis and liver cancer. Routine analysis to detect liver damage are transaminases levels in serum, with a false negative rate of 80%. The gold-standard method is liver biopsy, thatbiopsy, which implies liver hemorrhage, has an elevated cost and requires the intervention of highly specialize
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)